These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29116070)

  • 1. [The importance of C-terminal aspartic acid residue (D141) to the antirestriction activity of the ArdB (R64) protein].
    Kudryavtseva AA; Osetrova MS; Livinyuk VY; Manukhov IV; Zavilgelsky GB
    Mol Biol (Mosk); 2017; 51(5):831-835. PubMed ID: 29116070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antirestriction activities of KlcA (RP4) and ArdB (R64) proteins.
    Goryanin II; Kudryavtseva AA; Balabanov VP; Biryukova VS; Manukhov IV; Zavilgelsky GB
    FEMS Microbiol Lett; 2018 Dec; 365(23):. PubMed ID: 30239714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative analysis of antirestriction activity of R64 ArdA and ArdB proteins].
    Balabanov VP; Pustovoĭt KS; Zavil'gel'skiĭ GB
    Mol Biol (Mosk); 2012; 46(2):269-75. PubMed ID: 22670523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antirestriction Protein ArdB (R64) Interacts with DNA.
    Kudryavtseva AA; Okhrimenko IS; Didina VS; Zavilgelsky GB; Manukhov IV
    Biochemistry (Mosc); 2020 Mar; 85(3):318-325. PubMed ID: 32564736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid pKM101 encodes two nonhomologous antirestriction proteins (ArdA and ArdB) whose expression is controlled by homologous regulatory sequences.
    Belogurov AA; Delver EP; Rodzevich OV
    J Bacteriol; 1993 Aug; 175(15):4843-50. PubMed ID: 8393008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of the KlcA and ArdB proteins reveals a novel fold and antirestriction activity against Type I DNA restriction systems in vivo but not in vitro.
    Serfiotis-Mitsa D; Herbert AP; Roberts GA; Soares DC; White JH; Blakely GW; Uhrín D; Dryden DT
    Nucleic Acids Res; 2010 Mar; 38(5):1723-37. PubMed ID: 20007596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antirestriction activity of the IncI1 transmissive plasmid R64 ArdA protein].
    Zavil'gel'skiĭ GB; Letuchaia TA; Rastorguev SM
    Mol Biol (Mosk); 2004; 38(5):901-6. PubMed ID: 15554191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-Restriction Activity of ArdB Protein against EcoAI Endonuclease].
    Kudryavtseva AA; Alekhin VA; Lebedeva MD; Cséfalvay E; Weiserova M; Manukhov IV
    Mol Biol (Mosk); 2023; 57(1):101-105. PubMed ID: 36976744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IncI1 plasmid R64 encodes the ArsR protein that alleviates type I restriction.
    Rastorguev SM; Zavilgelsky GB; Tchurikov NA
    FEBS Lett; 1998 Apr; 426(1):21-3. PubMed ID: 9598970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antirestriction and antimodification activities of the ArdA protein encoded by the IncI1 transmissive plasmids R-64 and ColIb-P9].
    Zavil'gel'skiĭ GB; Letuchaia TA; Rastorguev SM
    Genetika; 2006 Mar; 42(3):331-8. PubMed ID: 16649659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ArdB Protective Activity for Unmodified λ Phage Against EcoKI Restriction Decreases in UV-Treated Escherichia coli.
    Balabanov VP; Kudryavtseva AA; Melkina OE; Pustovoit KS; Khrulnova SA; Zavilgelsky GB
    Curr Microbiol; 2019 Nov; 76(11):1374-1378. PubMed ID: 31407052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antirestriction and antimodification activities of the T7 Ocr protein: effect of mutations in interface].
    Zavil'gel'skiĭ GB; Kotova VIu; Rastorguev SM
    Mol Biol (Mosk); 2009; 43(1):103-10. PubMed ID: 19334532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antirestriction proteins ardA and Ocr as effective inhibitors of the type I restriction-modification enzymes].
    Zavil'gel'skiĭ GB; Rastorguev SM
    Mol Biol (Mosk); 2009; 43(2):264-73. PubMed ID: 19425495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadness and specificity: ArdB, ArdA, and Ocr against various restriction-modification systems.
    Kudryavtseva AA; Cséfalvay E; Gnuchikh EY; Yanovskaya DD; Skutel MA; Isaev AB; Bazhenov SV; Utkina AA; Manukhov IV
    Front Microbiol; 2023; 14():1133144. PubMed ID: 37138625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antirestriction protein Ard (Type C) encoded by IncW plasmid pSa has a high similarity to the "protein transport" domain of TraC1 primase of promiscuous plasmid RP4.
    Belogurov AA; Delver EP; Agafonova OV; Belogurova NG; Lee LY; Kado CI
    J Mol Biol; 2000 Mar; 296(4):969-77. PubMed ID: 10686096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of "anti-restriction" motif in functional activity of anti-restriction protein ArdA pKM101 (incN)].
    Rastorguev SM; Zavil'gel'skiĭ GB
    Genetika; 2003 Feb; 39(2):286-92. PubMed ID: 12669426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A motif conserved among the type I restriction-modification enzymes and antirestriction proteins: a possible basis for mechanism of action of plasmid-encoded antirestriction functions.
    Belogurov AA; Delver EP
    Nucleic Acids Res; 1995 Mar; 23(5):785-7. PubMed ID: 7708494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the domain forming the dimeric interface of the ArdA protein affect dimerization and antimodification activity but not antirestriction activity.
    Roberts GA; Chen K; Bower EK; Madrzak J; Woods A; Barker AM; Cooper LP; White JH; Blakely GW; Manfield I; Dryden DT
    FEBS J; 2013 Oct; 280(19):4903-14. PubMed ID: 23910724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid-encoded antirestriction protein ArdA can discriminate between type I methyltransferase and complete restriction-modification system.
    Nekrasov SV; Agafonova OV; Belogurova NG; Delver EP; Belogurov AA
    J Mol Biol; 2007 Jan; 365(2):284-97. PubMed ID: 17069852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antirestriction activity of the mercury resistance nonconjugative transposon Tn5053 is controlled by the protease ClpXP].
    Zavigel'skiĭ GB; Kotova VIu; Mel'kina OE; Pustovoĭt KS
    Genetika; 2014 Sep; 50(9):1033-9. PubMed ID: 25735133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.